Emerson Electric Co. (EMR)
| Previous close | 88.49 |
| Open | 89.79 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 900 |
| Day's range | 88.06 - 91.27 |
| 52-week range | 37.75 - 91.27 |
| Volume | 3,299,009 |
| Avg. volume | 2,687,510 |
| Market cap | 54.627B |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | 26.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.02 (2.22%) |
| Ex-dividend date | 11 Feb 2021 |
| 1y target est | N/A |
- Business Wire
Emerson Announces Strategic Appointments, Enhanced Focus on ESG with Chief Sustainability Officer
To enhance its focused efforts and purpose around environmental sustainability, global technology and industrial software leader Emerson (NYSE: EMR) today announced the appointment of its first chief sustainability officer. Mike Train, who has served as president since 2018 and a member of Emerson’s Office of the Chief Executive (OCE) since 2016, will step down as president to take on this new and important role for Emerson. Emerson also announced the promotion of Lisa Flavin, who currently serves as vice president and chief compliance officer, to senior vice president and chief compliance officer. Flavin will also join Emerson’s OCE. Emerson Chief Executive Officer Lal Karsanbhai has been named president.
- Business Wire
Emerson Introduces Digital Maturity Tool to Help Companies Target Digital Transformation Priorities
Manufacturers seeking to leverage new digital technologies to transform their businesses can turn to Emerson’s new Digital Maturity Quick Index to self-assess their operations and identify opportunities that deliver the highest potential return on investment. Global technology and software company Emerson (NYSE:EMR) has created a new, free online tool that builds upon several well-established maturity models and Emerson’s long-standing experience consulting and partnering with clients on their digital transformation programs.
- Business Wire
Emerson Invests in Fluxa
Emerson (NYSE: EMR), a technology and industrial software company, today announced it has made an equity investment in Fluxa, whose Process & Knowledge Management (PKM™) software seamlessly manages product and process specifications throughout the drug development lifecycle. The investment will build on Emerson’s leading life sciences capabilities and help Fluxa expand its technology development and commercial pipeline to deliver solutions to the market.
